UC Davis Comprehensive Cancer Center | Strategic Alliance Partners

As the therapy continues to evolve, best nursing practices become more nuanced.

Patients with metastatic renal cell carcinoma have multiple effective frontline treatment options.

The COVID-19 pandemic has affected oncology practice in many ways. What will safe treating look like moving forward?

Identifying targets early can help forestall resistance and improve the efficacy of osimertinib, a EGFR tyrosine kinase inhibitor, in the first-line setting.

Early lines of treatment for non-small cell lung cancer treatment might be effectively guided by minimal residual disease.

Mehrdad Abedi, MD, discusses the challenges of standard transplant, how Orca-T could overcome some of those limitations, and the potential future of transplant in hematologic malignancies.

The advent of 3D printing has led to an exciting revolution in limb salvage surgery for patients with bone tumors and soft tissue sarcomas, and have resulted in more precise resection and high-fidelity reconstruction, according to R. Lor Randall, MD, FACS.

Getting a cancer diagnosis is a lifechanging experience for all patients, but for those who live in rural areas, receiving appropriate care and treatment can pose additional challenges.